I was watching a Global News segment (against my will) the other day, and they presented the video of Dr. Stella Immanuel as misinformation and debunked. This story was on TV for about 15 seconds maximum.

Here is that same Global News story in article form: The argument of the article is that since one doctor believes in spirit demons, she is not credible. Well that's fine that one doctor isn't! But that doesn't mean the other doctors aren't credible either.

Well, here is another doctor with real credibility saying the same thing as that group of doctors. Global News, when can we expect the retraction?

The doctors in the video were criticizing this study. You have to go to bottom of the page to find the authors and the disclosure of conflict of interest which is here.. The argument of the doctors is that there is a massive conflict of interest here! The study was funded by EMS pharmaceuticals, "the biggest domestic pharmaceutical company in Brazil" with revenues exceeding 1 billion US dollars "which provided partial funding, the trial drugs, and logistic support." EMS pharma has a vested interest in making a profit off of profitable drugs. This study claims to discredit the validity of a marginally profitable, affordable, and well understood medicine that was approved decades ago while at the same time nations are investing billions of dollars of public money to development medicines. The US has bought up virtually all the stock of a key Covid-19 drug 'Remdesivir'.

Why is the media not addressing the valid, peer-reviewed concerns of this study? Peer-review is a fundamental component of the scientific method. Any doctor or scientist that cites this study without at-all addressing the conflict of interest has, in my view, failed in their most basic duty as proffesional scientists, and damages their own credibility.

Below in this text I will quote the study's authors own declared conflicts of interests from the disclosure of conflict of interest attached to the study:

Author 1: "Dr. Avezum reports grants, non-financial support and other from EMS pharmaceutical industry, during the conduct of the study; "

Author 2: "Dr. Berwanger reports grants, non-financial support and other from EMS pharmaceutical industry, during the conduct of the study; grants from AstraZeneca, grants from Bayer, grants from Boehringer-Ingelheim, grants from BMS, grants from Servier, grants from Novartis, outside the submitted work"

Author 3: "Dr. Bleuel Amazonas reports personal fees from EMS, outside the submitted work; "

Author 4: "Dr. Bocchi de Oliveira reports personal fees from EMS, outside the submitted work"

Author 5: "Dr. Cardoso reports grants, non-financial support and other from EMS pharmaceutical industry, during the conduct of the study;"

Author 6: "Dr. Cavalcanti reports grants, non-financial support and other from EMS pharmaceutical industry, during the conduct of the study;"

Author 7: "Dr. Petri Damiani reports grants, non-financial support and other from EMS, during the conduct of the study; "

Author 8: "Dr. OLIVEIRA DE ABREU-SILVA reports grants, non-financial support and other from EMS pharmaceutical industry, during the conduct of the study"

Author 9: "Dr. de Barros e Silva reports grants, non-financial support and other from EMS, during the conduct of the study; grants and personal fees from Pfizer, grants and personal fees from Roche Diagnostics, grants from Bayer, outside the submitted work; "

Author 10: "Dr. Echenique reports grants, non-financial support and other from EMS, during the conduct of the study;:"

Author 11: "Dr. Falavigna reports grants, non-financial support and other from EMS pharmaceutical industry, during the conduct of the study; other from HTAnalyze Consultoria e Treinamento LTDA, outside the submitted work; "

Author 12: "Dr. Freitas reports grants, non-financial support and other from EMS, during the conduct of the study;"

Author 13: "Dr. Furtado reports grants, non-financial support and other from EMS, during the conduct of the study; grants and personal fees from AstraZeneca, personal fees from Servier, grants from DalCor, grants from Behring, grants from Jansen, grants from Novartis , grants from Novo Nordisk, outside the submitted work; ."

Author 14: "Dr. Gebara reports grants, non-financial support and other from EMS, during the conduct of the study;"

Author 15: "Dr. Golin reports grants, non-financial support and other from EMS, during the conduct of the study; "

Author 16: "Dr. Hoffmann Filho reports grants, non-financial support and other from EMS, during the conduct of the study; ."

Author 17: "Dr. Junqueira reports grants, non-financial support and other from EMS, during the conduct of the study; ."

Author 18: "Dr. Kawano-Dourado reports grants, non-financial support and other from EMS, during the conduct of the study; ."

Author 19: "Dr. Kormann reports grants, non-financial support and other from EMS, during the conduct of the study; ."

Author 20: "Dr. Laranjeira reports grants, non-financial support and other from EMS, during the conduct of the study; ."

Author 21: "Dr. Lisboa reports grants, non-financial support and other from EMS, during the conduct of the study; ."

Author 22: "Dr. Lopes reports grants, non-financial support and other from EMS, during the conduct of the study; personal fees from Bayer, personal fees from Boehringer Ingleheim , grants and personal fees from Bristol-Myers Squibb, personal fees from Daiichi Sankyo, grants and personal fees from Glaxo Smith Kline, grants and personal fees from Metronic, personal fees from Merck, grants and personal fees from Pfizer, grants and personal fees from Portola, grants and personal fees from Sanofi, outside the submitted work; "

Author 23: "Dr. Machado reports grants, non-financial support and other from EMS, during the conduct of the study; ."

Author 24: "Dr. Maia reports grants, non-financial support and other from EMS, during the conduct of the study; ."

Author 25: "Dr. Marcadenti reports grants, non-financial support and other from EMS, during the conduct of the study; ."

Author 26: "Dr. MILAN reports grants, non-financial support and other from EMS, during the conduct of the study; ."

Author 27: "Dr. Pereira reports grants, non-financial support and other from EMS, during the conduct of the study; "

Author 28: "Dr. Pontes Azevedo reports grants, non-financial support and other from EMS, during the conduct of the study; personal fees from Halex Istar, personal fees from Baxter, personal fees from Pfizer, outside the submitted work"

Author 29: "Dr. Rosa reports grants, non-financial support and other from EMS, during the conduct of the study; ."

Author 30: "Dr. SOARES reports grants, non-financial support and other from EMS, during the conduct of the study; ."

Author 31: "Dr. Souza-Datas reports grants, non-financial support and other from EMS, during the conduct of the study; ."

Author 32: "Dr. Tramujas reports grants, non-financial support and other from EMS pharmaceutical industry, during the conduct of the study;"

Author 33: "Dr. Veiga reports grants, non-financial support and other from EMS, during the conduct of the study; ."

Author 34: "Dr. ZAMPIERI reports grants, non-financial support and other from EMS, during the conduct of the study; .